6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
7m ago	Veradermics Announces Launch of Public Offering
8m ago	New Jersey American Water Proudly Recognizes American Water Charitable Foundation 2026 Water and Environment Grantees
8m ago	Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting
8m ago	37 Capital Adopts Semi-Annual Financial Reporting
8m ago	Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

About

Taysha Gene Therapies Inc (NASDAQ:TSHA) — investor relations, events, news, and company updates on 6ix.

Latest News

Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting

Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update

Taysha Gene Therapies to Release Full-Year 2025 Financial Results and Host Conference Call and Webcast on March 19

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome

Financials

Revenue

$9.77 M

Market Cap

$1.33 B

EPS

-0.34

Community Chat

Ask AI